Erection problems in Trileptal - how severe and when it was recovered? (a real world drug study)
Summary:
We study how severe was Erection problems, when it was recovered, drug effectiveness, race, and more among people who take Trileptal (oxcarbazepine). This phase IV clinical study is created by eHealthMe based on reports submitted to eHealthMe, and is updated regularly.
What is Trileptal?
Trileptal has active ingredients of oxcarbazepine. It is often used in bipolar disorder. eHealthMe is studying from 23,558 Trileptal users. Check the latest studies of Trileptal.
What is Erection problems?
Erection problems is found to be associated with 1,274 drugs and 2,035 conditions by eHealthMe. Check the latest studies of Erection problems.
9 people who have Erection problems while taking Trileptal were studied.

Severity of Erection problems *:
- least: 0.0 %
- moderate: 50.0 %
- severe: 33.33 %
- most severe: 16.67 %
When people recovered from Erection problems *:
- while on drug: 0.0 %
- after off the drug: 0.0 %
- not yet: 100 %
Effectiveness of Trileptal *:
- not at all: 0.0 %
- somewhat: 28.57 %
- moderate: 28.57 %
- high: 42.86 %
- very high: 0.0 %
Race of the people *:
- African American, Non-Hispanic: 0.0 %
- American Indian/Alaska Native: 0.0 %
- Asian: 0.0 %
- Hispanic: 0.0 %
- Native Hawaiians/Pacific Islanders: 0.0 %
- Two or more races: 0.0 %
- White, Non-Hispanic: 100 %
Time on Trileptal *:
- < 1 month: 14.29 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 42.86 %
- 2 - 5 years: 42.86 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Age of people when taking Trileptal *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 22.22 %
- 40-49: 44.44 %
- 50-59: 11.11 %
- 60+: 22.22 %
Conditions people have *:
- Stress And Anxiety: 2 people, 22.22%
- High Blood Pressure: 2 people, 22.22%
- High Blood Cholesterol: 2 people, 22.22%
- Enlarged Prostate: 2 people, 22.22%
- Depression: 2 people, 22.22%
- Simple Partial Seizures (seizures which affect only a small region of the brain): 1 person, 11.11%
- Phobia (fear): 1 person, 11.11%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 11.11%
- Mood Swings (an extreme or rapid change in mood): 1 person, 11.11%
- Insomnia (sleeplessness): 1 person, 11.11%
Other drugs people take besides Trileptal *:
- Latuda: 2 people, 22.22%
- Zonisamide: 1 person, 11.11%
- Vitamins: 1 person, 11.11%
- Candex: 1 person, 11.11%
- Cialis: 1 person, 11.11%
- Clonazepam: 1 person, 11.11%
- Doxazosin Mesylate: 1 person, 11.11%
- Garlic Oil: 1 person, 11.11%
- Gilenya: 1 person, 11.11%
- Klonopin: 1 person, 11.11%
Other side effects people have besides Erection problems *:
- Vestibular Neuronitis (inflammation of the vestibular nerve): 1 person, 11.11%
- Tremor (trembling or shaking movements in one or more parts of your body): 1 person, 11.11%
- Spasticity (weakness and loss of muscle control due to nerve damage in brain): 1 person, 11.11%
- Optic Neuritis (optic nerve inflammation): 1 person, 11.11%
- Itching: 1 person, 11.11%
- High Blood Pressure: 1 person, 11.11%
- High Blood Cholesterol: 1 person, 11.11%
- Heat Intolerance (feeling of being overheated): 1 person, 11.11%
- Ejaculation Disorder: 1 person, 11.11%
- Chronic Fatigue Syndrome (disorder that causes extreme fatigue): 1 person, 11.11%
* Approximation only. Some reports may have incomplete information.
Do you take Trileptal and have Erection problems?
Check whether Erection problems is associated with a drug or a conditionHow to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
How the study uses the data?
The study is based on oxcarbazepine (the active ingredients of Trileptal). Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Lung Neoplasm Malignant and Lymphocyte Count Increased - 7 seconds ago
- Fainting and drugs of ingredients of simeprevir - 7 seconds ago
- Could Fastin cause Back Pain Aggravated? - 20 seconds ago
- Could Flexeril cause Craniosynostosis? - 22 seconds ago
- Could Ultiva cause Nausea And Vomiting? - 22 seconds ago
- Drug interactions of Finasteride and Glucosamine - 23 seconds ago
- Leukopenia and drugs of ingredients of ketoprofen - 30 seconds ago
- Could Namenda Xr cause High Blood Pressure? - 39 seconds ago
- Repatha and Brilinta drug interactions for women aged 50-59 - 52 seconds ago
- Drug interactions of Ergocalciferol and Herceptin - 58 seconds ago